Articles
|
Spring 2008
|
Legacy
Elliot Kaplan is glad he got his U of M law degree when he did: “Grade point averages of incoming students have risen so high, I wouldn’t get in today!” he says of the U’s position as a top Law School. Kaplan, ’57 B.A., ’61 J.D., has played a big part in achieving that greatness. He led a $55 million capital campaign and has served in numerous alumni advisory roles. The successful lawyer has come a long way since he worked his way though the U selling women’s shoes. Recently, he’s found a fit as
|
|
April 29, 2008
|
APaTS: Advanced Patent Trial Strategies
What's the amount of time necessary to separate a patent holder from an infringement verdict? In O2 Micro International, Ltd. v. Beyond Innovation Technology, Co., Ltd., 32 micro seconds was enough...
|
|
2008
|
First Focus: A Subprime Crisis, a Thomson-West Report
Lawsuits claiming that minorities have been the recipients of a disproportionate share of subprime mortgages have been fueled by recent data that mortgage bankers made public. This trend is likely to continue, as the lending practices of other banks and lending institutions are scrutinized, and other municipalities attempt to recoup the loss of tax revenue and other costs association with the growing number of foreclosures.
|
|
April 1, 2008
|
This material was prepared for a seminar in Atlanta to be held on April 22, 2008. Jennifer Adler will be a faculty member and speaker at the event.
|
|
April 1, 2008
|
This material was prepared for a seminar in Atlanta to be held on April 22, 2008. Jennifer Adler will be a faculty member and speaker at the event.
|
|
Mar 27, 2008
|
IP Law360
Paper manufacturer Georgia-Pacific Consumer Products LP sued Clorox Co. and its subsidiary Armor All/STP Products Co., alleging that the two companies infringed a patent regarding a container made specifically to hold wipes.
|
|
March 13, 2008
|
Last week, the FDA announced they have found an "unknown contaminant" in the blood-thinning drug heparin that is produced by Baxter HealthCare Corporation.
|
|
March 13, 2008
|
Increased property losses are only the beginning. Climate change raises issues across many lines of insurance.
|
|
February 29, 2008
|
Recently, serious adverse events have been reported in patients who received heparin manufactured by Baxter HealthCare Corporation.
|
|
February 21, 2008
|
APaTS
An APaTS summary of TiVo v. Echostar, in which the Federal Circuit engages in page after page of dense claim construction only to deliver the heart of the opinion in a single, concluding paragraph.
|